While the results show great promise, significant challenges remain in reducing algorithmic bias across demographic groups, validating performance with diverse external datasets, prospective clinical evaluations, standardization of performance metrics, and clear regulatory pathways towards deployment (203, 204)
Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy
Disclaimer: The contents of the Westlake Dermatology website, including text, graphics, and images, are for informational purposes only and are not intended to substitute for direct medical advice from your physician or other qualified professional
Zablotowicz RM et al
Use them on alternate days if possible
Cytosolic cysteine comes from only three sources: (1) from methionine via the methionine cycle and the transsulfuration pathway, (2) direct import into the cell from the plasma, and (3) from excess protein catabolism over protein synthesis